'Podnosis': A deep dive into the OTC approval of Narcan, the opioid overdose drug

This week, we'll introduce you to our sister podcast, "The Top Line."

On March 29, the FDA approved the Narcan nasal spray for over-the-counter sales. It is the first naloxone product approved for use without a prescription. In this episode of "The Top Line," Fierce Pharma staff writer Fraiser Kansteiner continues our miniseries to explore what that means for the opioid epidemic. The series will tackle questions about using the product, its accessibility and whether the move will save lives.

To learn more about the topics in this episode: 

"The Top Line" and "Podnosis" are produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

To Listen to More Episodes from Podnosis